Cardiol Therapeutics (CRDL) Amortizatization of Intangibles (2020 - 2024)

Cardiol Therapeutics has reported Amortizatization of Intangibles for 5 years, with the latest figure at $123252.7 in Q3 2024.

• For the quarter ending Q3 2024, Amortizatization of Intangibles rose 682.69% year-over-year to $123252.7; the trailing twelve-month figure through Dec 2024 stood at $154354.5 (up 146.63% YoY), and the FY2024 full-year result was $150584.6, up 142.77% from the prior year.
• Amortizatization of Intangibles for Q3 2024 stood at $123252.7, up from $15435.1 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $123252.7 in Q3 2024, with the low at $15225.3 in Q2 2020.
• Historically, Amortizatization of Intangibles has averaged $22029.9 across 5 years, with a median of $16014.5 in 2020.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles decreased 7.14% — and 2024, when it surged 682.69%.
• Cardiol Therapeutics' Amortizatization of Intangibles stood at $16193.3 in 2020, then advanced by 3.43% to $16748.1 in 2021, then retreated by 7.14% to $15552.5 in 2022, then declined by 0.29% to $15506.8 in 2023, then surged by 694.83% to $123252.7 in 2024.
• The last three Amortizatization of Intangibles figures came in at $123252.7 (Q3 2024), $15435.1 (Q2 2024), and $15666.8 (Q1 2024), per Business Quant data.